Literature DB >> 33093660

Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR.

Xinyu Xu1,2, Jonas Kaindl3, Mary J Clark4, Harald Hübner3, Kunio Hirata5,6, Roger K Sunahara7, Peter Gmeiner8, Brian K Kobilka1,2,9, Xiangyu Liu10,11.   

Abstract

Beta adrenergic receptors (βARs) mediate physiologic responses to the catecholamines epinephrine and norepinephrine released by the sympathetic nervous system. While the hormone epinephrine binds β1AR and β2AR with similar affinity, the smaller neurotransmitter norepinephrine is approximately tenfold selective for the β1AR. To understand the structural basis for this physiologically important selectivity, we solved the crystal structures of the human β1AR bound to an antagonist carazolol and different agonists including norepinephrine, epinephrine and BI-167107. Structural comparison revealed that the catecholamine-binding pockets are identical between β1AR and β2AR, but the extracellular vestibules have different shapes and electrostatic properties. Metadynamics simulations and mutagenesis studies revealed that these differences influence the path norepinephrine takes to the orthosteric pocket and contribute to the different association rates and thus different affinities.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33093660      PMCID: PMC8089101          DOI: 10.1038/s41422-020-00424-2

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   46.297


  56 in total

1.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

2.  Molecular basis for high-affinity agonist binding in GPCRs.

Authors:  Tony Warne; Patricia C Edwards; Andrew S Doré; Andrew G W Leslie; Christopher G Tate
Journal:  Science       Date:  2019-05-09       Impact factor: 47.728

3.  Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice.

Authors:  S Engelhardt; Y Grimmer; G H Fan; M J Lohse
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

4.  Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.

Authors:  W Z Zhu; M Zheng; W J Koch; R J Lefkowitz; B K Kobilka; R P Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.

Authors:  Wei-Zhong Zhu; Shi-Qiang Wang; Khalid Chakir; Dongmei Yang; Tong Zhang; Joan Heller Brown; Eric Devic; Brian K Kobilka; Heping Cheng; Rui-Ping Xiao
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.

Authors:  James A Maier; Carmenza Martinez; Koushik Kasavajhala; Lauren Wickstrom; Kevin E Hauser; Carlos Simmerling
Journal:  J Chem Theory Comput       Date:  2015-07-23       Impact factor: 6.006

7.  The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes.

Authors:  Yang Xiang; Eric Devic; Brian Kobilka
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

8.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

9.  Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.

Authors:  Ron O Dror; Daniel H Arlow; David W Borhani; Morten Ø Jensen; Stefano Piana; David E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-03       Impact factor: 11.205

10.  KAMO: towards automated data processing for microcrystals.

Authors:  Keitaro Yamashita; Kunio Hirata; Masaki Yamamoto
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-04-24       Impact factor: 7.652

View more
  16 in total

1.  Exploring the kinetic selectivity of drugs targeting the β1 -adrenoceptor.

Authors:  David A Sykes; Mireia Jiménez-Rosés; John Reilly; Robin A Fairhurst; Steven J Charlton; Dmitry B Veprintsev
Journal:  Pharmacol Res Perspect       Date:  2022-08

2.  Plasticity in ligand recognition at somatostatin receptors.

Authors:  Michael J Robertson; Justin G Meyerowitz; Ouliana Panova; Kenneth Borrelli; Georgios Skiniotis
Journal:  Nat Struct Mol Biol       Date:  2022-02-24       Impact factor: 18.361

Review 3.  Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair.

Authors:  Jordana I Borges; Krysten E Ferraino; Natalie Cora; Deepika Nagliya; Malka S Suster; Alexandra M Carbone; Anastasios Lymperopoulos
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

4.  Structural insights into ligand recognition, activation, and signaling of the α2A adrenergic receptor.

Authors:  Jun Xu; Sheng Cao; Harald Hübner; Dorothée Weikert; Geng Chen; Qiuyuan Lu; Daopeng Yuan; Peter Gmeiner; Zheng Liu; Yang Du
Journal:  Sci Adv       Date:  2022-03-04       Impact factor: 14.136

Review 5.  Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.

Authors:  Robert Root-Bernstein
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10

6.  Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.

Authors:  Giuseppe Deganutti; Kerry Barkan; Barbara Preti; Michele Leuenberger; Mark Wall; Bruno G Frenguelli; Martin Lochner; Graham Ladds; Christopher A Reynolds
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21

Review 7.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22

8.  Crystal structure of the α1B-adrenergic receptor reveals molecular determinants of selective ligand recognition.

Authors:  Lena Morstein; Matthias Schuster; Mattia Deluigi; Christoph Klenk; Lisa Merklinger; Riley R Cridge; Lazarus A de Zhang; Alexander Klipp; Santiago Vacca; Tasneem M Vaid; Peer R E Mittl; Pascal Egloff; Stefanie A Eberle; Oliver Zerbe; David K Chalmers; Daniel J Scott; Andreas Plückthun
Journal:  Nat Commun       Date:  2022-01-19       Impact factor: 14.919

9.  Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.

Authors:  Yuan Yuan; Guowen Jia; Chao Wu; Wei Wang; Lin Cheng; Qian Li; Ziyan Li; Kaidong Luo; Shengyong Yang; Wei Yan; Zhaoming Su; Zhenhua Shao
Journal:  Cell Res       Date:  2021-09-15       Impact factor: 25.617

Review 10.  Ligands of Adrenergic Receptors: A Structural Point of View.

Authors:  Yiran Wu; Liting Zeng; Suwen Zhao
Journal:  Biomolecules       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.